Teligent Research and Development Expenses 2010-2021 | TLGT
Teligent research and development expenses from 2010 to 2021. Research and development expenses can be defined as an expense arising from studies and product development processes.
Teligent Annual Research and Development Expenses
(Millions of US $) |
| 2020 |
$8 |
| 2019 |
$11 |
| 2018 |
$14 |
| 2017 |
$19 |
| 2016 |
$17 |
| 2015 |
$13 |
| 2014 |
$7 |
| 2013 |
$3 |
| 2012 |
$3 |
| 2011 |
$2 |
| 2010 |
$2 |
| 2009 |
$1 |
Teligent Quarterly Research and Development Expenses
(Millions of US $) |
| 2021-06-30 |
$2 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$2 |
| 2020-09-30 |
$2 |
| 2020-06-30 |
$2 |
| 2020-03-31 |
$2 |
| 2019-12-31 |
$3 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$3 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$4 |
| 2018-09-30 |
$3 |
| 2018-06-30 |
$4 |
| 2018-03-31 |
$3 |
| 2017-12-31 |
$6 |
| 2017-09-30 |
$5 |
| 2017-06-30 |
$5 |
| 2017-03-31 |
$4 |
| 2016-12-31 |
$5 |
| 2016-09-30 |
$4 |
| 2016-06-30 |
$5 |
| 2016-03-31 |
$4 |
| 2015-12-31 |
$4 |
| 2015-09-30 |
$3 |
| 2015-06-30 |
$3 |
| 2015-03-31 |
$3 |
| 2014-12-31 |
$2 |
| 2014-09-30 |
$2 |
| 2014-06-30 |
$2 |
| 2014-03-31 |
$1 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$1 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$1 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$0 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$0 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$0 |
| 2010-06-30 |
$0 |
| 2010-03-31 |
$0 |
| 2009-12-31 |
$0 |
| 2009-09-30 |
$0 |
| 2009-06-30 |
$0 |
| 2009-03-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
